Evaluation and Modeling with the Therapeutic Effects Group
Members

Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87

Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18

Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83

Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99

Praticienne hospitalière
HCL

Praticien hospitalier
HCL
Tel: 04 72 44 81 42

Professeur d'université - praticien hospitalier émérite
UCBL

Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01

Post-doc
UCBL

Maîtresse de conférences - praticienne hospitalière
UCBL
Doctorante
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20
Stagiaire
UCBL

Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Doctorante
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 91 to 120 publications on 653 in total
Outcomes of pregnancies with preterm premature rupture of membranes occurring before 24 weeks of gestation: An 11‐year observational study
International Journal of Gynecology and Obstetrics . 162 ( 2 ) : 590-595
DOI: 10.1002/ijgo.14700
Journal article
see the publicationDefining standard and high dosages for β-lactam agents administered by intermittent, prolonged or continuous infusion: a PK/PD simulation study
Journal of Antimicrobial Chemotherapy . 78 ( 11 ) : 2762–2769
DOI: 10.1093/jac/dkad300
Journal article
see the publicationA Knowledge-Based Approach for Evaluating Impact of Therapeutic Strategies
ICAART 2023 - 15th International Conference on Agents and Artificial Intelligence . 3 : 1036-1046
Conference paper
see the publicationPopulation designations in biomedical research: limitations and perspectives
HLA: Immune Response Genetics . 101 ( 1 ) : 3-15
DOI: 10.1111/tan.14852
Journal article
see the publicationThe COVID-19 Pandemic Impacted Maternal Mental Health Differently Depending on Pregnancy Status and Trimester of Gestation
International Journal of Environmental Research and Public Health . 19 ( 5 ) : 2926
Journal article
see the publicationExtreme Hyperferritinemia: Causes and Prognosis
Journal of Clinical Medicine . 11 ( 18 ) : 5438
DOI: 10.3390/jcm11185438
Journal article
see the publicationIron Deficiency in Cystic Fibrosis: A Cross-Sectional Single-Centre Study in a Referral Adult Centre
Nutrients . 14 ( 3 ) : 673
DOI: 10.3390/nu14030673
Journal article
see the publicationA New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report
Frontiers in Neuroscience . 16 : 906360
Journal article
see the publicationEpidemiology of major relapse in giant cell arteritis: A study-level meta-analysis
Autoimmunity Reviews . 21 ( 1 ) : 102930
Journal article
see the publicationWhat place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
Therapies . 78 ( 1 ) : 131-143
Journal article
see the publicationHow do they add up? The interaction between the placebo and treatment effect: A systematic review
British Journal of Clinical Pharmacology . 88 ( 8 ) : 3638-3656
DOI: 10.1111/bcp.15345
Journal article
see the publicationSGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
Diabetologia . 65 ( 12 ) : 2000-2010
Journal article
see the publicationProfiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
Pediatric Pulmonology . 57 ( 12 ) : 2992-2999
DOI: 10.1002/ppul.26123
Journal article
see the publicationReplacing liquid with solid dosage forms in pediatric practice: Feasibility and economic impact from a hospital-based study
Therapies . 77 ( 4 ) : 445-452
Journal article
see the publicationNirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
New England Journal of Medicine . 386 ( 9 ) : 837-846
Journal article
see the publicationImmune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients
Rheumatology . 61 ( 9 ) : 3627-3639
Journal article
see the publicationIntravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 11 ) : 2889-2895
Journal article
see the publicationThe consequences of COVID-19 pandemic on patients with monoclonal gammopathy–associated systemic capillary leak syndrome (Clarkson disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 2 ) : 626-629
Journal article
see the publicationQuelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Therapies . 78 ( 1 ) : 115-129
Journal article
see the publicationEstimating individualized treatment effects using individual participant data meta-analysis
Preprint
see the publicationA randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy – including photon and proton therapy – for the treatment of radioresistant tumors: the ETOILE trial
BMC Cancer . 22 ( 1 ) : 575
Journal article
see the publicationMachine-Learning Exploration of Exposure-Effect Relationships of Cisplatin in Head and Neck Cancer Patients
Pharmaceutics . 14 ( 11 ) : 2509
Journal article
see the publicationSGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
Diabetologia . 65 : 2000-2010
Journal article
see the publicationIndirect Comparison of Glucocorticoid-Sparing Agents for Remission Maintenance in Giant Cell Arteritis: A Network Meta-analysis
Mayo Clinic Proceedings . 97 ( 10 ) : 1824-1835
Journal article
see the publicationScreening for hypertension-mediated organ damage and aetiology: still of value after 65 years of age?
Journal of Geriatric Cardiology . 19 ( 11 ) : 791-801
Journal article
see the publicationIntravenous Immunoglobulins Tapering and Withdrawal in Systemic Capillary Leak Syndrome (Clarkson Disease)
Journal of Allergy and Clinical Immunology: In Practice . 10 ( 11 ) : 2889-2895
Journal article
see the publicationRéponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse
Revue du Rhumatisme . 89 ( 5 ) : 435-446
Journal article
see the publicationImmune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients
Rheumatology . 61 ( 9 ) : 3627-3639
Journal article
see the publicationAssessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Circulation . 146 ( 8 ) : 597-612
Journal article
see the publication
You also, comment on this article